Team:Paris Bettencourt/Delay

From 2012.igem.org

(Difference between revisions)
Line 10: Line 10:
* Construction and characterization of the simple delay system
* Construction and characterization of the simple delay system
** [http://partsregistry.org/Part:BBa_K914004 K914004] : P<sub>BAD</sub>-AraC-RBS-LacI ; [https://2012.igem.org/Team:Paris_Bettencourt/Delay#Characterization characterization]
** [http://partsregistry.org/Part:BBa_K914004 K914004] : P<sub>BAD</sub>-AraC-RBS-LacI ; [https://2012.igem.org/Team:Paris_Bettencourt/Delay#Characterization characterization]
-
** [http://partsregistry.org/Part:BBa_K914009 K914009] : P1003* Ser133->Amber Codon : kanamycin gene resistance with 1 amber mutation
+
* Characterization of the sRNA repression system of Yokobayashi ''et al.'' : [https://2012.igem.org/Team:Paris_Bettencourt/Delay#Refined_characterization_of_the_Yokobayashi_et_al._sRNA_repression_plasmidic_device click here]
The first part (supD) is well characterized and works well. For the second parts, it turns out that this mutation is quite leaky, although it works in lab conditions, one mutation is not enough if we want to release such parts in nature. Other reasons emphasize this observation, notably the weakness of being at one mutation to recover the protein functionality.
The first part (supD) is well characterized and works well. For the second parts, it turns out that this mutation is quite leaky, although it works in lab conditions, one mutation is not enough if we want to release such parts in nature. Other reasons emphasize this observation, notably the weakness of being at one mutation to recover the protein functionality.

Revision as of 18:47, 26 September 2012


iGEM Paris Bettencourt 2012

Delay system(s)

Achievements :

  • Construction and characterization of the simple delay system
    • [http://partsregistry.org/Part:BBa_K914004 K914004] : PBAD-AraC-RBS-LacI ; characterization
  • Characterization of the sRNA repression system of Yokobayashi et al. : click here

The first part (supD) is well characterized and works well. For the second parts, it turns out that this mutation is quite leaky, although it works in lab conditions, one mutation is not enough if we want to release such parts in nature. Other reasons emphasize this observation, notably the weakness of being at one mutation to recover the protein functionality.

  • Creation of a new category in the part registry : [http://partsregistry.org/Biosafety Semantic containment]. The aim of this category is to let people improving each part by adding for instance other amber mutations to existing part to increase the containment.

Contents

Overview

In order to let our genetically modified organism perform its task in the environment, for example sensing nitrate concentration, and in the same time trigger the death of the organism and degradation of its DNA we need to design a delay system that will separate this two task in time. Give a real example of the application.

This part of the design will trigger the DNA degradation mechanism. To do so, we will use two different approaches. The first one, that we called "simple delay system", will be a way to trigger a restriction enzyme, which will cut the plasmid carrying the antitoxin, and thus let the cell sensitive to the toxin produced on the chromosome. In the "sRNA delay system, we use a different strategy. Here, the toxin would be cloned without the Immunity protein, in order to avoid any possible resistance to the toxin due to a non-degraded plasmid. To ensure that the toxin will not be produced while the cells are performing their function, we will use a stationary phase promoter and sRNA repression induced by arabinose.

Paris Bettencourt Delay overview.png

Simple delay system

Objectives

Design

Characterization

ParisBettencourt12SimpleDelay.png

sRNA delay system

Objectives

As an alternative trigger to the «collective suicide» presented in the overview of the project, we tried to build a system in which the toxin would be cloned without the Immunity protein, in order to avoid any possible resistance to the toxin due to a non-degraded plasmid. Such a design comes with several difficulties :

  • we need a very strong repression of the expression of the toxin. A leaky expression would harm the cells, and one of the risks is that mutants which do not produce the toxin arise and become selected.
  • we need to be able to have a control on the delay, in order for the cells to trigger the safety mechanism only once they have performed their function.
  • we need to be sure that the safety system will be triggered at one point. We prioritize the robustness of the delay over its timespan.

Design

We want to use a sRNA as a way to block the expression of the toxin. The concept of our design is described below. Similar systems have been shown to respond in a treshold-linear way [2]

SRNAparisbett.png

In order to achieve our goal, we started form the construct of Yokobayashi et al. [1] described below.

Odparisbett.png

Even though the cloning is still in process, we hope to build the following construct by the end of the competition.

Finaldesignparisbett.png

The transcription of the toxin is controlled twice : first, we chose a stationary phase promoter, yiaGp. It is known be recognized by the sigma-S subunit of the RNA polymerase, and not the exponential phase sigma-70 subunit. [3], [4].

We have shown that the yiaGp promoter is indeed activated during the stationary phase in our construct, even though the level of trancription is rather low (see experiments)

In order to achieve a complete lockdown of the toxin, we added a second repression mechanism, this time at the post transcriptional level. We used and modified the constructs of Yokobayashi et al. to allow a repression of the translation using sRNA [1]. We chose to use the sRNA 7.9, as it has been shown to bind the leader sequence of its target mRNA and not its coding sequence, and to allow a 20 fold repression of the protein’s expression. The transcription of the sRNA is under the control of the pBAD promoter. The coding sequence of colicin E2 is fused to the leader sequence (5’ UTR) of OmpF. The araC protein allows us to use this construct in cells deleted for the arabinose operon (TOP10). We hope that, using this type of cells, the delay will depend on the dilution of the arabinose in the medium as it is not metabolized. We will need to check the effect of extracellular glucose on the level of repression, as the CRP protein is known to repress the pBAD promoter.

Experiments and results

Characterisation of the YiaGp promoter

Using the following construct, we characterized the stationary phase YiaGp promoter in TOP10 cells.

GFP-YiaGp.png

Experimental setup

The cells were diluted 100 fold in LB one hour before the experiment We performed the experiment on a 96-wells plate reader, using plain LB as a fluorescence control. We monitored the fluorescence of GFP (excitation/emission=470nm/515nm) and the optical density (600nm).

We plotted the average of (Fluo-Fluo LB)/(OD-OD LB) for the 6 replicates over time.

Results

Present your results

Refined characterization of the Yokobayashi et al. sRNA repression plasmidic device

Experimental setup

We double transformed TOP10 cells with pKP33-GFPuv and pBAD-aOmpF-7.9 (see [1] for details, and click here for a schematic of the genetic system). We chose the 7.9 sRNA because it seemed to show a strong repression of the GFP expression, and bind to the

Results

Present your results

References

1. Sharma, V., Yamamura, A., & Yokobayashi, Y. (2012). Engineering Artificial Small RNAs for Conditional Gene Silencing in Escherichia coli, 6-13. [http://pubs.acs.org/doi/abs/10.1021/sb200001q| Paper]

2. Levine, E., Zhang, Z., Kuhlman, T., & Hwa, T. (2007). Quantitative characteristics of gene regulation by small RNA. PLoS biology, 5(9), e229. doi:10.1371/journal.pbio.0050229 [http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.0050229| Paper]

3. Sharma, U. K., & Chatterji, D. (2010). Transcriptional switching in Escherichia coli during stress and starvation by modulation of sigma activity. FEMS microbiology reviews, 34(5), 646-57. doi:10.1111/j.1574-6976.2010.00223.x[http://jb.asm.org/content/186/21/7112.long| Paper]

4. Shimada, T., Makinoshima, H., Ogawa, Y., Miki, T., Maeda, M., & Ishihama, A. (2004). Classification and Strength Measurement of Stationary-Phase Promoters by Use of a Newly Developed Promoter Cloning Vector, 186(21), 7112-7122. doi:10.1128/JB.186.21.7112 [http://onlinelibrary.wiley.com/doi/10.1111/j.1574-6976.2010.00223.x/abstract;jsessionid=8C98B1B383242B9DFF45429802F48428.d02t04| Paper]

Copyright (c) 2012 igem.org. All rights reserved. Design by FCT.